keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Thursday, September 26, 2024 - Day Three - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Thursday, September 26, 2024 - Day Three - ET (Eastern Time, GMT-05:00)
search
Streams
8:00am - 8:55am
Registration and Morning Coffee
Showing 3 of 3 Streams
Gene Therapy Manufacturing
Non Viral Delivery Development & Manufacturing
Analytical, Quality & Bioprocessing 4.0
8:55am - 9:00am
Chairperson's Remarks: Gene Therapy Manufacturing
9:00am - 9:30am
Strategies to increase removal of impurities and viral concentration during Production and Downstream Purification
- Unpacking the current barriers to RNA gene therapy use
- Advancements in the processing of RNA to improve outcomes (remove unwanted cells, viral concentration, purification)
- Scalable processes
9:30am - 10:00am
Improving Yield of Recovered Capsids during Downstream Recovery
- Seema Bhatlekar - Scientist, Johnson & Johnson Innovative Medicine
10:00am - 10:30am
Scientific Track Presentation by Refeyn
8:55am - 9:00am
Chairperson's Remarks: Non Viral Delivery Development & Manufacturing
- Shashi Murthy, PhD - CTO and Co-Founder, Nanite Inc.
9:00am - 9:30am
Polymer-Drug Conjugates: Revolutionizing Therapy with Enhanced Delivery and Efficacy
- Tailored design and engineering of polymeric nanoparticles for optimal cell interaction, targeting, and therapeutic delivery.
- Diverse delivery strategies and tissue targeting approaches for specific disease applications
- Effective encapsulation techniques to preserve cell viability, functionality, and differentiation potential during delivery
- Case study: how are these being explored/used
9:30am - 10:00am
Rapid Enzymatic Synthesis and Scaling of DNA Gene Therapy Molecules
- Anthony Dawson - Senior Scientist, Generation Bio
10:00am - 10:30am
Scientific Track Presentation
8:55am - 9:00am
Chairperson's Remarks: Analytical, Quality & Bioprocessing 4.0
9:00am - 9:30am
Total Analytical Control Strategy for Base Editing Gene Therapy
- Johnson Varghese - Head of Analytical Sciences & Development, Beam Therapeutics
9:30am - 10:00am
Total Control Strategy for Cellular Therapeutics – Smaller, Faster, Earlier Analytics
Dark Horse Consulting Representative
10:00am - 10:30am
Scientific Track Presentation
10:30am - 11:15am
Networking Refreshment Break in the Exhibit Hall
Showing 3 of 3 Streams
CGT Supply Chain,, Logistics and Market Access
Non Viral Delivery Development & Manufacturing
Analytical, Quality & Bioprocessing 4.0
11:15am - 11:45am
Exploring the Evolving Landscape of Supply Chain Management for CGT: Innovations, Tools, and Trends
- Jared Auclair - Associate Dean of Professional Program and Graduate Affairs, College of Science at Northeastern University
11:45am - 12:15pm
Extending the Shelf Life of Single-Use Consumables
- Michelle Parziale - Senior Engineer - MS&T, Moderna
12:15pm - 12:45pm
Scientific Track Presentation by Avantor
11:15am - 11:45am
Harnessing the Power of Extracellular Vesicles for Non-Viral Gene Therapy
- Qin Yu - VP of Research, Vesigen Therapeutics
11:45am - 12:15pm
Engineered Extracellular Vesicles for Clinical Application
- Christopher Locher - CEO & Co-Founder, Versatope, USA
12:15pm - 12:45pm
Scientific Track Presentation by Aldevron
11:15am - 11:45am
Comparability Studies for Analytical Assessment Process Change
- Yiwei Zhao - Director, Analytical Development, Mural Oncology
11:45am - 12:15pm
Using Mass Spec for HCP Analysis – Pros and Cons of Immunoassays vs Mass Spec for HCP Analysis
- Nadine Ritter, Ph.D. - President and Analytical Advisor, Global Biotech Experts, LLC
12:15pm - 12:45pm
Scientific Track Presentation
12:45pm - 2:00pm
Luncheon in the Exhibit Hall (last chance to meet with exhibitors)
Showing 3 of 3 Streams
CGT Supply Chain,, Logistics and Market Access
Non Viral Delivery Development & Manufacturing
Analytical, Quality & Bioprocessing 4.0
2:00pm - 3:00pm
Overcoming Hurdles when distributing CGTs Across Multiple Regions and Markets
- Amish Patel - SVP, Technical Operations, Calidi Biotherapeutics
- Ben Doak - National Senior Programme of Care Manager - Innovative Treatments, NHS England
2:00pm - 2:30pm
Strategic CMC considerations, challenges and opportunities for nonviral gene therapies
- Nathan Lee - Senior Director, Gene Therapy CMC, Poseida Therapeutics
2:30pm - 3:00pm
Unleashing the power of machine learning design toward personalized and multi-functional Non-Viral delivery systems
- Shashi Murthy, PhD - CTO and Co-Founder, Nanite Inc.
2:00pm - 2:30pm
ADC Analytical Strategy to Set Up Appropriate Criteria
- David Lee - Executive Director, Analytical Chemistry, Mersana Therapeutics
2:30pm - 3:00pm
Bispecific Impurities During Development – Discovery, Characterization and Assessment of a Novel Bispecific Impurity
- Monica Sadek - Technical Development Scientist 2, Protein Analytical Chemistry, Genentech
3:00pm - 3:05pm
Close of conference
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams